Posted May 13, 2020

While the world continues its fight against novel coronavirus, researchers and private industry have banded together in order to slow the spread of the virus and develop new tests and treatments for Covid-19. Now, more than ever, it is evident that collaboration is necessary to overcome current challenges and nowhere is as uniquely qualified to help foster these collaborations than Huntsville’s HudsonAlpha Institute for Biotechnology.

At the outset of the Covid-19 pandemic, the companies residing on HudsonAlpha’s biotech campus have increased laboratory testing capacity, launched point-of-care testing diagnostics, advanced early stage antibody treatments for immune response, provided researchers with critical reagents for Covid-19 projects and researched personal protective equipment sterilization methods for the reuse of PPE equipment.

Much of this progress can be attributed to the HudsonAlpha ecosystem that promotes collaboration on solving some of the world’s most challenging problems.

Read the rest here